Taladegib Patent Grant for Pulmonary Fibrosis Treatment
Summary
The USPTO granted patent US12605379B2 to Endeavor BioMedicines, Inc. covering methods of treating pulmonary fibrosis using taladegib. The patent includes 29 claims and covers CPC classifications A61K 31/502 and A61P 11/00. The filing date was September 12, 2025.
What changed
The USPTO issued patent grant US12605379B2 to Endeavor BioMedicines, Inc. for methods of improving lung function through administration of taladegib to subjects with pulmonary fibrosis. The patent covers pharmaceutical composition claims under CPC classification A61K 31/502. Pharmaceutical and biotechnology companies developing or commercializing hedgehog pathway inhibitors for respiratory indications should review this patent to assess potential freedom-to-operate implications for their programs.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods of improving lung function
Grant US12605379B2 Kind: B2 Apr 21, 2026
Assignee
Endeavor BioMedicines, Inc.
Inventors
Miguel de los Rios, John Hood, Anita J. DiFrancesco, Luis A. Dellamary, Paul A. Frohna
Abstract
The present disclosure provides methods of treating pulmonary fibrosis, the methods comprising administering taladegib to a subject in need thereof.
CPC Classifications
A61K 31/502 A61P 11/00
Filing Date
2025-09-12
Application No.
19327682
Claims
29
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.